ZNF708
gene geneOn this page
Also known as KOX8
Summary
ZNF708 (zinc finger protein 708, HGNC:12945) is a protein-coding gene on chromosome 19p12, encoding Zinc finger protein 708 (P17019). May be involved in transcriptional regulation.
Predicted to enable DNA binding activity and zinc ion binding activity. Predicted to be involved in regulation of DNA-templated transcription. Predicted to be located in membrane and nucleus.
Source: NCBI Gene 7562 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 71 total
- MANE Select transcript:
NM_021269
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:12945 |
| Approved symbol | ZNF708 |
| Name | zinc finger protein 708 |
| Location | 19p12 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | KOX8 |
| Ensembl gene | ENSG00000182141 |
| Ensembl biotype | protein_coding |
| Entrez | 7562 |
Gene structure
Transcript identifiers
Ensembl transcripts: 5 — 3 protein_coding, 1 nonsense_mediated_decay, 1 protein_coding_CDS_not_defined
ENST00000356929, ENST00000598046, ENST00000601295, ENST00000602023, ENST00000718342
RefSeq mRNA: 3 — MANE Select: NM_021269
NM_001297560, NM_001297561, NM_021269
CCDS: CCDS32980
Canonical transcript exons
ENST00000356929 — 4 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001714924 | 21310501 | 21310627 |
| ENSE00004034823 | 21329210 | 21329410 |
| ENSE00004034824 | 21309246 | 21309341 |
| ENSE00004034826 | 21291160 | 21294739 |
Expression profiles
Bgee: expression breadth ubiquitous, 198 present calls, max score 84.43.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 17.3337 / max 1519.6763, expressed in 1737 samples.
FANTOM5 promoters (6 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 180211 | 8.1116 | 1472 |
| 180210 | 5.9004 | 1468 |
| 180209 | 2.2363 | 838 |
| 208745 | 0.4563 | 216 |
| 180207 | 0.3861 | 87 |
| 180208 | 0.2429 | 21 |
Top tissues by expression
247 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| cortical plate | UBERON:0005343 | 84.43 | gold quality |
| calcaneal tendon | UBERON:0003701 | 83.73 | gold quality |
| adrenal tissue | UBERON:0018303 | 83.14 | gold quality |
| colonic epithelium | UBERON:0000397 | 83.00 | gold quality |
| ganglionic eminence | UBERON:0004023 | 82.70 | gold quality |
| C1 segment of cervical spinal cord | UBERON:0006469 | 81.88 | gold quality |
| bone marrow cell | CL:0002092 | 81.53 | gold quality |
| corpus callosum | UBERON:0002336 | 81.21 | gold quality |
| sural nerve | UBERON:0015488 | 80.75 | gold quality |
| spinal cord | UBERON:0002240 | 79.67 | gold quality |
| oviduct epithelium | UBERON:0004804 | 79.66 | gold quality |
| ventricular zone | UBERON:0003053 | 78.30 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 77.51 | gold quality |
| vermiform appendix | UBERON:0001154 | 77.20 | gold quality |
| islet of Langerhans | UBERON:0000006 | 77.04 | gold quality |
| leukocyte | CL:0000738 | 76.81 | gold quality |
| left ovary | UBERON:0002119 | 76.65 | gold quality |
| monocyte | CL:0000576 | 76.61 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 76.35 | gold quality |
| prefrontal cortex | UBERON:0000451 | 75.99 | gold quality |
| buccal mucosa cell | CL:0002336 | 75.98 | silver quality |
| tendon | UBERON:0000043 | 75.91 | gold quality |
| ovary | UBERON:0000992 | 75.69 | gold quality |
| tibial nerve | UBERON:0001323 | 75.53 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 75.26 | gold quality |
| lymph node | UBERON:0000029 | 75.25 | gold quality |
| body of pancreas | UBERON:0001150 | 74.75 | gold quality |
| right ovary | UBERON:0002118 | 74.63 | gold quality |
| pancreas | UBERON:0001264 | 74.56 | gold quality |
| rectum | UBERON:0001052 | 74.32 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 4.35 |
Regulation
Is transcription factor: yes
JASPAR motifs
| Motif | Name | Family |
|---|---|---|
| MA1730.1 | ZNF708 | More than 3 adjacent zinc fingers |
| MA1730.2 | ZNF708 | More than 3 adjacent zinc fingers |
JASPAR matrix evidence (PMIDs): PMID:28273063
miRNA regulators (miRDB)
96 targeting ZNF708, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-3925-3P | 100.00 | 69.95 | 1237 |
| HSA-MIR-6833-3P | 100.00 | 70.63 | 3197 |
| HSA-MIR-4768-5P | 100.00 | 69.49 | 2861 |
| HSA-MIR-6873-3P | 100.00 | 71.42 | 2626 |
| HSA-MIR-3064-3P | 100.00 | 70.09 | 1254 |
| HSA-MIR-548C-3P | 99.99 | 74.01 | 7587 |
| HSA-MIR-4775 | 99.98 | 75.00 | 6394 |
| HSA-MIR-8068 | 99.98 | 73.85 | 2376 |
| HSA-MIR-548N | 99.98 | 71.94 | 4170 |
| HSA-MIR-27A-3P | 99.98 | 72.13 | 2955 |
| HSA-MIR-27B-3P | 99.98 | 72.13 | 2955 |
| HSA-MIR-9985 | 99.98 | 72.11 | 2939 |
| HSA-MIR-607 | 99.97 | 73.62 | 5593 |
| HSA-MIR-495-3P | 99.96 | 72.81 | 4197 |
| HSA-MIR-5688 | 99.96 | 73.23 | 4504 |
| HSA-MIR-590-3P | 99.96 | 74.34 | 6478 |
| HSA-MIR-4666A-3P | 99.96 | 71.71 | 3434 |
| HSA-LET-7C-3P | 99.95 | 73.42 | 2862 |
| HSA-MIR-23A-3P | 99.95 | 74.24 | 3163 |
| HSA-MIR-23B-3P | 99.95 | 74.24 | 3163 |
| HSA-MIR-1236-3P | 99.94 | 68.04 | 1695 |
| HSA-MIR-6845-3P | 99.94 | 66.88 | 1439 |
| HSA-MIR-338-5P | 99.92 | 72.34 | 2951 |
| HSA-MIR-1297 | 99.91 | 73.41 | 3162 |
| HSA-MIR-6809-3P | 99.91 | 71.45 | 3814 |
| HSA-MIR-5680 | 99.91 | 69.83 | 3421 |
| HSA-MIR-374A-5P | 99.90 | 71.34 | 2923 |
| HSA-MIR-153-5P | 99.89 | 73.86 | 6317 |
| HSA-MIR-221-5P | 99.86 | 65.45 | 1052 |
| HSA-MIR-8073 | 99.86 | 65.21 | 1118 |
Cross-species orthologs
0 orthologs
Paralogs (176): ZNF195 (ENSG00000005801), ZNF112 (ENSG00000062370), ZNF275 (ENSG00000063587), ZNF37A (ENSG00000075407), ZNF510 (ENSG00000081386), ZNF506 (ENSG00000081665), ZNF268 (ENSG00000090612), MZF1 (ENSG00000099326), ZNF629 (ENSG00000102870), ZNF175 (ENSG00000105497), ZNF85 (ENSG00000105750), ZFP30 (ENSG00000120784), ZNF45 (ENSG00000124459), ZNF391 (ENSG00000124613), ZNF436 (ENSG00000125945), ZNF484 (ENSG00000127081), ZNF835 (ENSG00000127903), ZNF780B (ENSG00000128000), ZSCAN10 (ENSG00000130182), ZNF317 (ENSG00000130803), ZNF331 (ENSG00000130844), ZNF227 (ENSG00000131115), ZNF141 (ENSG00000131127), ZNF132 (ENSG00000131849), ZNF189 (ENSG00000136870), ZIM3 (ENSG00000141946), ZFP14 (ENSG00000142065), ZNF514 (ENSG00000144026), ZNF300 (ENSG00000145908), RBAK (ENSG00000146587), ZNF157 (ENSG00000147117), ZNF182 (ENSG00000147118), ZNF41 (ENSG00000147124), ZNF7 (ENSG00000147789), ZNF117 (ENSG00000152926), ZNF221 (ENSG00000159905), ZNF235 (ENSG00000159917), ZNF714 (ENSG00000160352), ZNF577 (ENSG00000161551), ZNF12 (ENSG00000164631)
Protein
Protein identifiers
Zinc finger protein 708 — P17019 (reviewed: P17019)
Alternative names: Zinc finger protein 15, Zinc finger protein 15-like 1, Zinc finger protein KOX8
All UniProt accessions (4): P17019, M0QYN4, M0R1G3, M0R2V2
UniProt curated annotations — full annotation on UniProt →
Function. May be involved in transcriptional regulation.
Subcellular location. Nucleus.
Similarity. Belongs to the krueppel C2H2-type zinc-finger protein family.
RefSeq proteins (3): NP_001284489, NP_001284490, NP_067092* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001909 | KRAB | Domain |
| IPR013087 | Znf_C2H2_type | Domain |
| IPR036051 | KRAB_dom_sf | Homologous_superfamily |
| IPR036236 | Znf_C2H2_sf | Homologous_superfamily |
Pfam: PF00096, PF01352
UniProt features (22 total): zinc finger region 15, sequence variant 4, chain 1, domain 1, modified residue 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-P17019-F1 | 76.11 | 0.19 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (1): 544
Function
Pathways and Gene Ontology
Reactome pathways
2 pathways
| ID | Pathway |
|---|---|
| R-HSA-212436 | Generic Transcription Pathway |
| R-HSA-9843940 | Regulation of endogenous retroelements by KRAB-ZFP proteins |
MSigDB gene sets: 98 (showing top):
GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_UP, GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_UP, chr19p12, HOFFMANN_SMALL_PRE_BII_TO_IMMATURE_B_LYMPHOCYTE_UP, MARTORIATI_MDM4_TARGETS_FETAL_LIVER_UP, IVANOVA_HEMATOPOIESIS_EARLY_PROGENITOR, MARSON_BOUND_BY_FOXP3_UNSTIMULATED, GOMF_SEQUENCE_SPECIFIC_DNA_BINDING, MIKKELSEN_ES_ICP_WITH_H3K4ME3, MIKKELSEN_NPC_ICP_WITH_H3K4ME3, BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_A, BYSTRYKH_HEMATOPOIESIS_STEM_CELL_QTL_TRANS, GCNP_SHH_UP_EARLY.V1_UP, REACTOME_EPIGENETIC_REGULATION_OF_GENE_EXPRESSION, GOMF_TRANSCRIPTION_REGULATOR_ACTIVITY
GO Biological Process (1): regulation of DNA-templated transcription (GO:0006355)
GO Molecular Function (3): DNA binding (GO:0003677), zinc ion binding (GO:0008270), metal ion binding (GO:0046872)
GO Cellular Component (2): nucleus (GO:0005634), membrane (GO:0016020)
Reactome top-level categories
Rollup of top-2 pathways:
| Category | Pathways |
|---|---|
| RNA Polymerase II Transcription | 1 |
| Regulation of endogenous retroelements | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| DNA-templated transcription | 1 |
| regulation of gene expression | 1 |
| regulation of RNA biosynthetic process | 1 |
| nucleic acid binding | 1 |
| transition metal ion binding | 1 |
| cation binding | 1 |
| intracellular membrane-bounded organelle | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
602 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| ZNF708 | SREK1IP1 | Q8N9Q2 | 453 |
| ZNF708 | SFXN3 | Q9BWM7 | 452 |
| ZNF708 | CREG2 | Q8IUH2 | 449 |
| ZNF708 | KRTAP19-2 | Q3LHN2 | 447 |
| ZNF708 | LEMD3 | Q9Y2U8 | 426 |
| ZNF708 | KIAA1958 | Q8N8K9 | 420 |
| ZNF708 | WIPF1 | O43516 | 412 |
| ZNF708 | P2RX1 | P51575 | 405 |
| ZNF708 | OR51A2 | Q8NGJ7 | 399 |
| ZNF708 | OR4C5 | Q8NGB2 | 397 |
| ZNF708 | GNG12 | Q9UBI6 | 394 |
| ZNF708 | DNAAF8 | Q8IYS4 | 393 |
| ZNF708 | PDE6B | P35913 | 376 |
| ZNF708 | POMZP3 | Q6PJE2 | 375 |
| ZNF708 | SIX4 | Q9UIU6 | 366 |
IntAct
18 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| TRIM28 | ZNF320 | psi-mi:“MI:0914”(association) | 0.530 |
| ZNF708 | KRT8 | psi-mi:“MI:0915”(physical association) | 0.400 |
| ECE1 | ZNF708 | psi-mi:“MI:0915”(physical association) | 0.370 |
| TRIM28 | ZNF320 | psi-mi:“MI:0914”(association) | 0.350 |
| RPL27A | ZNF320 | psi-mi:“MI:0914”(association) | 0.350 |
| PURG | ZNF320 | psi-mi:“MI:0914”(association) | 0.350 |
| ZKSCAN8 | ZNF320 | psi-mi:“MI:0914”(association) | 0.350 |
| NOTCH2 | ZNF320 | psi-mi:“MI:0914”(association) | 0.350 |
| LTBP2 | ZNF320 | psi-mi:“MI:0914”(association) | 0.350 |
| ANKRD36B | CCDC66 | psi-mi:“MI:0914”(association) | 0.350 |
| RPL36 | GTPBP10 | psi-mi:“MI:0914”(association) | 0.350 |
| ANOS1 | ZNF724 | psi-mi:“MI:0914”(association) | 0.350 |
| ZNF543 | TRIM24 | psi-mi:“MI:0914”(association) | 0.350 |
| ZNF653 | URB1 | psi-mi:“MI:0914”(association) | 0.350 |
| ZNF708 | OCM2 | psi-mi:“MI:0914”(association) | 0.350 |
| TIMM50 | ZNF320 | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (20): ZNF708 (Affinity Capture-MS), ZNF708 (Affinity Capture-RNA), ZNF708 (Proximity Label-MS), ZNF708 (Affinity Capture-MS), ZNF708 (Affinity Capture-MS), ZNF708 (Affinity Capture-MS), TOR2A (Affinity Capture-MS), GJD4 (Affinity Capture-MS), ZNF708 (Affinity Capture-MS), OCM2 (Affinity Capture-MS), ZNF708 (Affinity Capture-MS), ZNF708 (Affinity Capture-MS), ZNF708 (Affinity Capture-MS), ZNF708 (Affinity Capture-MS), ZNF708 (Affinity Capture-MS)
ESM2 similar proteins: A6NDX5, A6NK75, A6NNF4, A6NP11, B4DXR9, B7Z6K7, C9JN71, O43361, O75290, O75373, P0CJ79, P0DKX0, P17019, P17021, P17035, P17039, P35789, Q02386, Q03938, Q08AN1, Q13106, Q15928, Q3ZCX4, Q5R9F0, Q5SXM1, Q68EA5, Q6P9A1, Q6PDB4, Q6ZN06, Q6ZN08, Q6ZNG1, Q76KX8, Q86V71, Q86XN6, Q8IYB9, Q8N4W9, Q8NEP9, Q8TBZ8, Q8TC21, Q8TF32
Diamond homologs: A0A1W2PQL4, A6NK75, A6NN14, A6NNF4, A6NP11, A8MQ14, A8MTY0, A8MUV8, A8MXY4, B4DX44, B4DXR9, E9PYI1, O14628, O43345, O75290, O75346, O75373, O75437, O95780, P0CB33, P0DKX0, P0DPD5, P16373, P17019, P17038, P21506, P35789, P52736, P52738, P52744, Q03923, Q03924, Q03936, Q03938, Q05481, Q14586, Q14593, Q14929, Q15928, Q3KNS6
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
71 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 66 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
969 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 19:21294735:CATAG:C | acceptor_gain | 1.0000 |
| 19:21309241:CCTA:C | donor_loss | 1.0000 |
| 19:21309244:A:AT | donor_loss | 1.0000 |
| 19:21309245:C:T | donor_loss | 1.0000 |
| 19:21309343:T:C | acceptor_loss | 1.0000 |
| 19:21310493:AT:A | donor_gain | 1.0000 |
| 19:21310540:T:A | donor_gain | 1.0000 |
| 19:21294737:TAG:T | acceptor_gain | 0.9900 |
| 19:21294739:GC:G | acceptor_loss | 0.9900 |
| 19:21294740:C:A | acceptor_loss | 0.9900 |
| 19:21294740:C:CC | acceptor_gain | 0.9900 |
| 19:21294741:T:C | acceptor_loss | 0.9900 |
| 19:21309339:TAC:T | acceptor_gain | 0.9900 |
| 19:21310494:T:C | donor_gain | 0.9900 |
| 19:21329204:TCTCA:T | donor_loss | 0.9900 |
| 19:21329205:CTCA:C | donor_loss | 0.9900 |
| 19:21329206:TCAC:T | donor_loss | 0.9900 |
| 19:21329207:CACCA:C | donor_loss | 0.9900 |
| 19:21329208:ACCA:A | donor_loss | 0.9900 |
| 19:21329209:C:T | donor_loss | 0.9900 |
| 19:21329244:G:C | donor_gain | 0.9900 |
| 19:21294736:ATAG:A | acceptor_gain | 0.9800 |
| 19:21329222:T:TA | donor_gain | 0.9800 |
| 19:21294738:AG:A | acceptor_gain | 0.9700 |
| 19:21301970:C:CT | donor_gain | 0.9700 |
| 19:21301971:T:TT | donor_gain | 0.9700 |
| 19:21309342:C:CC | acceptor_gain | 0.9700 |
| 19:21309344:G:C | acceptor_loss | 0.9700 |
| 19:21310493:A:AC | donor_gain | 0.9700 |
| 19:21311755:C:CT | acceptor_gain | 0.9700 |
AlphaMissense
3757 scored. Top likely-pathogenic:
dbSNP variants (sampled 300 via entrez): RS1000022648 (19:21295889 T>C), RS1000044199 (19:21318924 G>A,C), RS1000237470 (19:21299983 C>T), RS1000296168 (19:21314544 A>G), RS1000352718 (19:21307622 G>A,T), RS1000379690 (19:21300918 C>T), RS1000525710 (19:21301041 T>A), RS1000542945 (19:21319353 T>C), RS1000555095 (19:21301456 T>C), RS1000602920 (19:21326802 C>T), RS1000671301 (19:21320570 G>T), RS1000717802 (19:21307390 C>T), RS1000986530 (19:21325653 T>C), RS1000995735 (19:21293920 G>A), RS1001053834 (19:21295563 T>A)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
24 total (human), top 24 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Valproic Acid | decreases methylation, affects expression, decreases expression | 4 |
| aristolochic acid I | decreases expression | 1 |
| 3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide | decreases expression | 1 |
| dicrotophos | decreases expression | 1 |
| triphenyl phosphate | affects expression | 1 |
| trichostatin A | affects expression | 1 |
| benzo(e)pyrene | increases methylation | 1 |
| aflatoxin B2 | decreases methylation | 1 |
| perfluorooctane sulfonic acid | decreases expression | 1 |
| pentabromodiphenyl ether | decreases expression | 1 |
| K 7174 | increases expression | 1 |
| 2,2’,4,4’-tetrabromodiphenyl ether | decreases expression | 1 |
| Sunitinib | decreases expression | 1 |
| Benzo(a)pyrene | affects methylation | 1 |
| Doxorubicin | decreases expression | 1 |
| Ethyl Methanesulfonate | increases expression | 1 |
| Methapyrilene | increases methylation | 1 |
| Methyl Methanesulfonate | increases expression | 1 |
| Quercetin | decreases expression | 1 |
| Tobacco Smoke Pollution | decreases expression | 1 |
| Vanadates | decreases expression | 1 |
| 1-Methyl-4-phenylpyridinium | decreases expression | 1 |
| Aflatoxin B1 | increases methylation | 1 |
| Aflatoxin M1 | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.